OmniStar Financial Group’s Pfizer PFE Stock Holding History

OmniStar Financial Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-27,796	Closed	-$1.09M	–	164
2021 Q2	$1.09M	Buy	+27,796	New	+$1.08M	1.35%	25

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OmniStar Financial Group's PFE Position: Q1 2023 in Review

OmniStar Financial Group sold out of Pfizer (PFE) in Q1 2023, closing a stake of 6,806 shares — an estimated $349K sold.

OmniStar Financial Group first reported a position in PFE in Q4 2017 and held it in 20 quarters. The position peaked at $2M in Q2 2018. 3,103 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

OmniStar Financial Group reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
OmniStar Financial Group sold 6,806 Pfizer shares in Q1 2023, an estimated $349K.
OmniStar Financial Group first reported a position in Pfizer in Q4 2017 and held it in 20 quarters.
OmniStar Financial Group's Pfizer position peaked at $2M in Q2 2018.
3,103 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on OmniStar Financial Group's 13F filing for Q1 2023, filed 1 May 2023.